Immediate
Initiation of Antiretroviral Therapy for HIV Infection Accelerates Bone Loss
Relative to Deferring Therapy: Findings from the START Bone Mineral Density
Substudy, a Randomized Trial.
Hoy JF, Grund B, Roediger M,
J Bone Miner Res. 2017
Jun 26.
Abstract
Effect of Antiretroviral Therapy on Bone and Renal Health in Young Adults
Infected with HIV in Early Life.
Unsal AB, Mattingly AS, Jones SE,
et al
J Clin Endocrinol Metab.
2017 May
Abstract
A Single Dose Zoledronic Acid Infusion Prevents Antiretroviral
Therapy-Induced Bone Loss in Treatment-naïve HIV-infected Patients: a Phase
IIb Trial.
Ofotokun I, Titanji K, Lahiri CD,
et al
Clin Infect Dis. 2016
May 18.
Abstract
Protecting bone in long-term HIV positive patients receiving
antiretrovirals.
McGinty T, Mallon P.
Expert Rev Anti Infect Ther.
2016 May 18
Abstract
Role of T-cell reconstitution in HIV-1 antiretroviral therapy-induced bone
loss.
Ofotokun I, Titanji K, Vikulina T, et al
Nat Commun. 2015 Sep
22;6:8282.
Abstract
Vitamin D and Calcium Attenuate Bone Loss With Antiretroviral
Therapy Initiation: A Randomized Trial.
Overton ET, Chan ES, Brown TT, et al
Ann Intern Med.
2015 Jun 16;
Abstract
Prevalence of and risk factors for low bone mineral density
in untreated HIV infection: a substudy of the INSIGHT Strategic Timing of
AntiRetroviral Treatment
START) trial.
Carr A, Grund B, Neuhaus J, et al
HIV Med.
2015
Apr;16 Suppl 1:137-46.
Abstract
Low Baseline CD4+ Count is Associated with Greater Bone Mineral
Density Loss after ART Initiation.
Grant PM, Kitch D, McComsey GA, et al
Clin Infect Dis. 2013 Aug 13.
Abstract
Impact of antiretroviral therapy on bone metabolism markers in
HIV-seropositive patients.
de Menezes Barbosa EG, de Paula FJ, Machado A, et al
Bone. 2013 Jul 24..
Abstract
Changes in bone mineral density over a two-year period in
HIV-1-infected men under cART with osteopenia.
Assoumou L, Katlama C, Viard JP, et al
AIDS. 2013 Jun 3..
Abstract
Body Composition, Soluble
Markers of Inflammation, and Bone Mineral Density in
Antiretroviral Therapy-Naïve HIV-1 Infected Individuals.
Brown TT, Chen Y, Currier JS, et al
J Acquir Immune Defic Syndr.
2013 Apr 15.
Abstract |
Fractures after antiretroviral initiation: An
analysis of the ACTG longitudinal linked randomized trial
(ALLRT) study.
Yin MT, Kendall MA, Wu X,
et al
AIDS.
2012 Aug 28..
Abstract
Markers of bone turnover are elevated in
patients with antiretroviral treatment independent of the
substance used.
Piso RJ, Rothen M, Rothen JP, Stahl M.
J Acquir Immune Defic Syndr.
2011 Apr;56(4):320-4.
Abstract
|
General
Reports 
HAART
Adverse Events
Documents identified with this icon are in Portable Document Format (PDF)
and require the
Adobe
Acrobat Reader